Carotenoids and cancer: Prevention and potential therapy

British Journal of Biomedical Science

Volumn 55, Issue 4, 1998, Pages 268-275

  Smith, Timothy A D ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Carotenoids; Epidemiology; Neoplasms; Primary prevention; Therapeutics

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; CAROTENOID; LYCOPENE; RETINOL; XANTHOPHYLL;

ARTICLE; CANCER; CANCER PREVENTION; CELL COMMUNICATION; CELL TRANSFORMATION; CLINICAL TRIAL; DIETARY INTAKE; DNA DAMAGE; FRUIT; GAP JUNCTION; HUMAN; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; SMOKING; TUMOR CELL LINE; VEGETABLE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

BETA CAROTENE; CAROTENOIDS; DIET; FEMALE; HUMANS; MALE; NEOPLASMS;

EID: 0032449901     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Gerster H. Anticarcinogenic effect of common carotenoids. Int J Vitam Nutr Res 1993; 63: 93-121.
2. Greenberg ER. Retinoids or carotenoids: is there another choice? Prev Med 1993; 22:723-7.
3. Zheng W, Blot WJ, Diamond EL et al. Serum micronutrients and the subsequent risk of oral and pharyngeal cancer. Cancer Res 1993; 53:795-8.
4. Nomura AM, Ziegler RG, Stemmermann GN, Chyou PH, Craft NE. Serum micronutrients and upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers Prev 1997; 6:407-12.
5. Day GL, Shore RE, Blot WJ et al. Dietary factors and second primary cancers: a follow up of oral and pharyngeal cancer patients. Nutr Canc. 1994; 21:223-32.
6. Yong LC, Brown CC, Schatzkin A et al. Intake of vitamins E, C and A and risk of lung cancer. The NHANES I epidemiologic follow-up study. First National Health and Nutritional Examination Survey. Am J Epidemiol 1997; 146:231-43.
7. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willet WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995; 87:1767-76.
8. Di Mascio P, Kaiser S, Sies H. Lycopene as the most effective biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989; 274:532-8.
9. Stahl W, Sies H. Lycopene: a biologically important carotenoid for humans? Arch Biochem Biophys 1996; 336:1-9.
10. Clinton SK, Emenhiser C, Schwartz SJ. Cis-trans lycopene isomers, carotenoids and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 1996; 5:823-33.
11. Comstock GW, Helzlsouer K, Bush T. Prediagnostic serum levels of carotenoids and vit E as related to subsequent cancer in Washington county, Maryland. Am J Clin Nutr 1991; 53:260-4S.
12. Helzlsouer KJ, Alberg AJ, Norkus EP, Morris JS, Huoffman SC, Comstock GW. Prospective study of serum micronutrients and ovarian cancer. J Natl Cancer Inst 1996; 88:32-7.
13. Hunter DJ, Colditz GA, Stampfer MJ, Rosner B, Willet WC, Speizer FE. Diet and risk of basal cell carcinoma of the skin in a prospective cohort of women. Ann Epidemiol 1992; 2:231-9.
14. Vena JE, Graham S, Freudenheim J. Diet in the epidemiology of bladder cancer in western New York. Nutr Cancer 1992; 18:255-64.
15. Engle A, Muscat JE, Harris RE. Nutritional risk factors and ovarian cancer. Nutr Cancer 1991; 15:239-47.
16. Potischman N, Brinton LA. Nutrition and cervical neoplasia. Cancer Causes Control 1996; 7:113-26.
17. Muscat JE, Huncharek M. Dietary intake and the risk of malignant mesothelioma. Br J Cancer 1996; 73:1122-5.
18. London SJ, Stein EA, Henderson IC. Carotenoids, retinol, and vitamin E and risk of proliferative benign breast disease and breast cancer. Cancer Causes Control 1992; 3:503-12.
19. Rock CL, Saxe GA, Ruffin MT IV. Carotenoids, vitamin A and estrogen receptor status in breast cancer. Nutr Cancer 1996; 25:281-96.
20. Ingram D. Diet and subsequent survival of women with breast cancer. Br J Cancer 1994; 69:592-5.
21. Olmedilla B, Granado F, Blanco I, Rojas-Hildalgo E. Evaluation of retinol, alpha-tocopherol, and carotenoids in serum of men with cancer of the larynx before and after commercial enteral formula feeding. J Parenter Enteral Nutr 1996; 20:145-9.
22. Pappalardo G, Maiani G, Mobarhan S et al. Plasma (carotenoids, retinol, alphatocopherol) and tissue (carotenoids) levels after supplementation with beta-carotene in subjects with precancerous and cancerous lesions of sigmoid colon. Eur J Clin Nutr 1997; 51:661-6.
23. Potischman N, Hoover RN, Brinton LA. The relations between cervical cancer and serological markers of nutritional status. Nutr Cancer 1994; 21:193-201.
24. Witte JS, Longnecker MP, Bird CL, Lee ER, Frankl HD, Haile RW. Relation of vegetable, fruit and grain consumption to colorectal adenomatous polyps. Am J Epidemiol 1996; 144: 1015-25.
25. Shikany JM, Witte JS, Henning SM. Plasma carotenoids and the prevalence of adenomatous polyps of the distal colon and rectum. Am J Epidemiol 1997; 145:552-7.
26. Sempos CT, Johnson NE, Smith EL, Gillan C. Effects of intraindividual and interindividual variation in repeated dietary records. Am J Epidemiol 1985; 121:120-30.
27. Salvini S, Hunter DJ, Sampson L et al. Food based validation of dietary questionnaire: the effects of week to week variation in food. Int J Epidemiol 1989; 18:858-67.
28. Albanes D, Heinonen OP, Taylor PR et al. α-Tocopherol and β-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996; 88:1560-70.
29. Omenn GS, Goodman GE, Thornquist MD et al. Risk factors for lung cancer and for intervention effects in CARAT, the beta-carotene and retinol efficacy trial. J Natl Cancer Inst 1996; 88:1550-9.
30. Heinonen OP, Albanes D, Virtamo J et al. Prostate cancer supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998; 90:440-6.
31. Pool-Zobel BL, Bub A, Muller H, Wollowski I, Rechkemmer G. Consumption of vegetables reduced genetic damage in humans: first results of a human intervention trial with carotenoid-rich foods. Carcinogenesis 1997; 18:1847-50.
32. Wienke JK, Kelsey KT, Varkonyi A. Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung. Cancer Res 1995; 55:4910-14.
33. Sies H, Stahl W, Sundquist AR. Antioxidant functions of vitamins. Vitamins E and C, beta-carotene, and other carotenoids. Ann NY Acad Sci 1992; 669:7-20.
34. Bollag W, Holdener EE. Retinoids in cancer prevention and therapy. Ann Oncol 1992; 3:513-26.
35. Brietman TR, Sellonick SE, Collins SJ. Induction of differentiation of human promyelocytic leukaemia cell lines (HL60) by retinoic acid. PNAS 1980; 77:2936-40.
36. Murakoshi M, Nishino H, Satomi Y. Potent preventative action of alpha-carotene against carcinogenesis: spontaneous liver carcinogenesis and promoting stage of lung and skin carcinogenesis in mice are suppressed more effectively by alpha-carotene than by beta-carotene. Cancer Res 1992; 52:6583-7.
37. Santamaria L, Bianchi A, Ravetto C, Arnaboldi A, Santagati G, Andreoni L. Prevention of gastric cancer induced by N-methyl-N′-nitro-N-nitrosoguanidine in rats fed supplemental carotenoids. J Nutr Growth Cancer 1987; 4:175-81.
38. Schwartz JL, Shklar G. Retinol and carotenoid angiogenesis: a possible explanation for oral carcinogenesis. Nutr Cancer 1997; 27:192-9.
39. Tanaka T, Morishita Y, Suzui M, Kojima T, Okumura A, Mori H. Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin. Curcinogenesis 1994; 15:15-19.
40. Nair SC, Kurmboor SK, Hasegawa JH. Saffron chemoprevention in biology and medicine: a review. Cancer Biother 1995; 10:257-64.
41. Wang W, Higuchi CM. Induction of NAD(P)H:quinone reductase by vitamins A, E and C in colo205 colon cancer cells. Cancer Lett 1995; 98:63-9.
42. Gradelat S, Astorg P, Leclerc J, Chevalier J, Vernevaut MF, Siess MH. Effects of canthaxanthin, lycopene, and lutein on liver xenobiotic-metabolizing enzymes in rat. Xenobiotica 1996; 26:49-63.
43. 1 metabolism. Carcinogenesis 1998; 19:403-11.
44. Bertram JS, Bortkiewicz H. Dietary carotenoids inhibit neoplastic transformation and modulate gene expression in mouse and human cells. Am J Clin Nutr 1995; 62:1327-355.
45. Zhang LX, Cooney RV, Bertram JS. Carotenoids up-regulate connexin43 gene expression independent of their provitamin A or antioxidant properties. Cancer Res 1992; 52:5707-12.
46. Klaunig JE, Ruch RJ. Role of inhibition of intracellular communication in carcinogenesis. Lab Invest 1990; 62:135-46.
47. Mehta PP, Holtz-Wagenblatt A, Rose B, Shalloway D, Loenstein WR. Incorporation of the gene for cell-cell channel protein into transformed cells leads to normalization of growth. J Membr Biol 1989; 124:207-25.
48. Schwartz J, Shklar G. The selective cytotoxic effect of carotenoids and alpha-tocopherol on human cancer cell lines in vitro. J Oral Maxillofac Surg 1992; 50:367-73.
49. Abdullaev FI. Inhibitory effect of crocetin on intracellular nucleic acid and protein synthesis in malignant cells. Toxicol Lett 1994; 70:243-51.
50. Galligan LJ, Jackson CL, Gerber LE. Carotenoids slow the growth of small cell lung cancer cells. Ann NY Acad Sci 1993; 691:267-9.
51. Levy J, Bosin E, Feldman B et al. Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene. Nutr Cancer 1995; 24:257-66.
52. Toma S, Losardo PL, Vincent M, Palumbo R. Effectiveness of beta-carotene in cancer chemoprevention. Eur J Canc Prev 1995; 4:213-24.